Renovaro entered into a binding agreement merger agreement with Predictive Oncology, Inc. (“POI”) dated January 1, 2025, and supplemented with the Extension Agreement dated February 28, 2025 ...

Meghan Markle opened up about launching her lifestyle brand, As ever, in a new interview with Inc, including what's next for ...

Discover the top 3 undervalued Commercial Services & Supplies stocks for Friday, April 04 based on AAII’s Stock Grades.

The transaction remains subject to final approval by the TSX Venture Exchange and is expected to be completed in the second quarter of 2025 upon completion of all required filings and approvals.

Xenon Pharmaceuticals Inc. , a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced ...

While the Consumer Financial Protection Act remains valid law, the reduction in federal enforcement is likely to lead to ...

Speaking at Dublin's Storyhouse, the filmmakers behind films such as 'Earth Mama,' 'X+Y' and 'Spilt Milk' spoke about their ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, presented NeuLogiq® ...

On Wednesday, two pharmacy benefit managers filed a motion to recuse U.S. District Judge Dan Polster after he failed to order ...

Trump administration policies on tariffs, renewable energy and electric vehicles are creating uncertainty in the marketplace, ...

Warner Bros. Discovery Inc. Series A closed 27.87% below its 52-week high of $12.70, which the company reached on December ...

U.S. stock markets plummeted after the opening bell Thursday, as investors registered shock at President Donald Trump's ...